Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia
| Image |  |
|---|---|
| Description | scientific article published on 25 June 2015 |
| Author/s |
author: Gianantonio Rosti Giuliana Alimena Gabriele Gugliotta Michele Baccarani Francesco Cavazzini Fausto Castagnetti Giovanni Martinelli GIMEMA Working Party on Chronic Myeloid Leukemia Simona Soverini Bruno Martino Monica Bocchia Carmen Fava Marzia Salvucci Mariella D'Adda Massimo Breccia Elena Trabacchi Fabrizio Pane Luciano Levato Michele Cedrone Mario Tiribelli Fabio Stagno Antonella Russo Rossi Giuseppe Saglio Maria Teresa Bochicchio Michele Cavo Emilio Usala |
| Publication date | June 25, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |